Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RP-A501
RP-A501
Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward
Fierce Biotech
Wed, 09/13/23 - 11:30 am
Rocket Pharmaceuticals
gene therapy
FDA
clinical trials
RP-A501
Danon disease
New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns
Fierce Biotech
Sun, 10/2/22 - 08:04 pm
Rocket Pharmaceuticals
gene therapy
clinical trials
RP-A501
Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease
Pharmaceutical Business Review
Wed, 06/19/19 - 09:52 am
Rocket Pharmaceuticals
gene therapy
Danon disease
RP-A501
Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder
CP Wire
Mon, 11/26/18 - 10:01 am
Rocket Pharmaceuticals
RP-A501
Danon disease
Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder
Mon, 11/26/18 - 09:46 am
Rocket Pharmaceuticals
RP-A501
Danon disease
